Columbia’s Dian Yang is placing CRISPR-based molecular recorders into cancer cells to eavesdrop on cancer evolution and pinpoint when and how cells metastasize.
Misinformation and outdated beliefs about screening tests, treatment options, and effects on sexual health continue to cloud understanding about this disease.
The Columbia community gathered in the Hudson Valley for the eighth annual Velocity: Columbia’s Ride to End Cancer. This year’s event raised more than $1 million and attracted nearly 600 participants.
Columbia researchers have engineered bacteria as personalized cancer vaccines that activate the immune system to specifically seek out and destroy cancer cells.
A new study suggests that a type of brain tumor in patients with neurofibromatosis type 1 could be treated with immunotherapy, which has so far proved ineffective in treating most brain cancers.
Anil K. Rustgi, MD, an expert in gastrointestinal tumors, will join Columbia University Irving Medical Center and NewYork-Presbyterian as director of the Herbert Irving Comprehensive Cancer Center.
A new study found that women with cervical cancer who had a radical hysterectomy with minimally invasive surgery had a significantly higher risk of death than those who had open surgery.
A new study shows how certain cells ‘cheat’ during cell competition to eliminate their neighbors and take over tissues; the findings could point toward new strategies for treating cancer.
Leaders in prostate cancer research and care will convene Sept. 22 for the inaugural NYC Prostate Cancer Summit, a patient-focused event co-hosted by CUIMC and NewYork-Presbyterian.
Physician-scientist Darrell Yamashiro, MD, PhD, has been named director of Columbia's Division of Pediatric Hematology, Oncology, & Stem Cell Transplantation.